文献速递生殖医学

体外受精前输卵管积水硬化治疗:系统评价与Meta分析

Hydrosalpinx Sclerotherapy Before In Vitro Fertilization: Systematic Review and Meta-analysis.
PubMed 文献 · J Minim Invasive Gynecol · 2017-12-14

本系统评价与Meta分析评估输卵管积水抽吸联合或不联合硬化治疗对复发风险及体外受精结局的疗效,共纳入10项研究。结果显示硬化治疗与输卵管切除术在临床妊娠率或流产率上无差异;单纯抽吸较切除术临床妊娠率显著降低且流产率显著升高;较无干预则临床妊娠率显著升高而流产率相似。作者认为体外受精前硬化治疗可改善生育结局,可作为输卵管切除术的替代方案。

要点

  • 输卵管积水抽吸联合或不联合硬化治疗的总体复发率分别为21.7%至30.5%和21.8%至32.5%。
  • 硬化治疗与输卵管切除术在临床妊娠率或流产率上无差异。
  • 单纯抽吸较无干预临床妊娠率显著升高,流产率相似。

核心结论

  • 体外受精前输卵管积水硬化治疗可改善生育结局,可作为输卵管切除术的替代方案。

研究设计与样本

  • 系统评价与Meta分析,检索PubMed、Embase、Ovid MEDLINE、Google Scholar、ClinicalTrials.gov和Cochrane Central Register of Controlled Trials,共纳入10项研究。

主要发现

  • 输卵管积水抽吸联合或不联合硬化治疗的总体复发率分别为21.7%至30.5%和21.8%至32.5%。
  • 硬化治疗与输卵管切除术在临床妊娠率或流产率上无差异。
  • 与输卵管切除术相比,单纯输卵管积水抽吸的临床妊娠率显著降低且流产率显著升高。
  • 与无干预相比,输卵管积水抽吸的临床妊娠率显著升高而流产率相似。

临床怎么用

  • 作者认为体外受精前输卵管积水硬化治疗可改善生育结局,可作为输卵管切除术的替代方案。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The presence of a hydrosalpinx has been shown to impair the outcome of in vitro fertilization (IVF) treatment. This outcome can be improved by removing the hydrosalpinx; however, there are some concerns regarding its feasibility and safety, especially in women with previous surgeries and dense adhesions. The purpose of our meta-analysis was to evaluate the efficacy of hydrosalpinx aspiration with or without sclerotherapy on the risk of recurrence and the IVF outcome compared with salpingectomy or no intervention. We performed an electronic-based search using PubMed, Embase, Ovid MEDLINE, Google Scholar, ClinicalTrials.gov, and the Cochrane Central Register of Controlled Trials. Our main outcome measures were the recurrence rate, fertility outcome, and adverse events. Ten studies were included in our review. The overall recurrence rates of hydrosalpinx aspiration with or without sclerotherapy were 21.7% to 30.5% and 21.8% to 32.5%, respectively. There was no difference in the clinical pregnancy or miscarriage rate between hydrosalpinx sclerotherapy and salpingectomy. When compared with salpingectomy, hydrosalpinx aspiration only was associated with a significantly lower clinical pregnancy rate and higher miscarriage rate. Compared with no intervention, hydrosalpinx aspiration resulted in significantly higher clinical pregnancies rates but a similar miscarriage rate. We conclude that hydrosalpinx sclerotherapy before IVF improves the fertility outcome and can be used as an alternative to salpingectomy.

来源:J Minim Invasive Gynecol,查看原文。版权归原作者所有。

引用

  1. Cohen A, Almog B, Tulandi T, et al. Hydrosalpinx Sclerotherapy Before In Vitro Fertilization: Systematic Review and Meta-analysis. J Minim Invasive Gynecol. 2017. PMID: 29248666. doi:10.1016/j.jmig.2017.12.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。